Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dessì C[au]:

Network dynamics in nanofilled polymers. Baeza GP et al. Nat Commun. (2016)

Deferasirox and children: From clinical trials to the real world. Origa R et al. Am J Hematol. (2016)

Current growth patterns in children and adolescents with thalassemia major. Origa R et al. Blood. (2016)

Search results

Items: 1 to 50 of 58

1.

Benthic Crustacean Digestion Can Modulate the Environmental Fate of Microplastics in the Deep Sea.

Cau A, Avio CG, Dessì C, Moccia D, Pusceddu A, Regoli F, Cannas R, Follesa MC.

Environ Sci Technol. 2020 Mar 30. doi: 10.1021/acs.est.9b07705. [Epub ahead of print]

PMID:
32189493
2.

Knowledge about cancer screening programmes in Sardinia.

Mereu A, Concu F, Dessì C, Girau M, Ionta MT, Lai L, Liori A, Masala M, McGilliard CD, Origa P, Piazza MF, Pisanu L, Soggiu B, Sotgiu A, Contu P, Sardu C.

J Prev Med Hyg. 2019 Dec 20;60(4):E337-E342. doi: 10.15167/2421-4248/jpmh2019.60.4.1094. eCollection 2019 Dec.

3.

Microplastics in the crustaceans Nephrops norvegicus and Aristeus antennatus: Flagship species for deep-sea environments?

Cau A, Avio CG, Dessì C, Follesa MC, Moccia D, Regoli F, Pusceddu A.

Environ Pollut. 2019 Dec;255(Pt 1):113107. doi: 10.1016/j.envpol.2019.113107. Epub 2019 Aug 26.

PMID:
31671310
4.

Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission.

Cadoni C, De Felice M, Corongiu S, Dessì C, Espa E, Melis M, Fenu S.

Addict Biol. 2019 Jul 24:e12803. doi: 10.1111/adb.12803. [Epub ahead of print]

PMID:
31342609
5.

Adolescence versus adulthood: Differences in basal mesolimbic and nigrostriatal dopamine transmission and response to drugs of abuse.

Corongiu S, Dessì C, Cadoni C.

Addict Biol. 2020 Jan;25(1):e12721. doi: 10.1111/adb.12721. Epub 2019 Feb 18.

PMID:
30779271
6.

Impact of the direct-acting antiviral agents (DAAs) on chronic hepatitis C in Sardinian patients with transfusion-dependent Thalassemia major.

Ponti ML, Comitini F, Murgia D, Ganga R, Canu R, Dessì C, Foschini ML, Leoni G, Morittu M, Perra M, Pilia MP, Casini MR, Zappu A, Origa R.

Dig Liver Dis. 2019 Apr;51(4):561-567. doi: 10.1016/j.dld.2018.12.016. Epub 2019 Jan 3.

PMID:
30658940
7.

Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited.

Derchi G, Dessì C, Bina P, Cappellini MD, Piga A, Perrotta S, Tartaglione I, Giuditta M, Longo F, Origa R, Quarta A, Pinto V, Forni GL; Webthal®.

Intern Emerg Med. 2019 Apr;14(3):365-370. doi: 10.1007/s11739-018-1890-2. Epub 2018 Jun 12.

PMID:
29948832
8.

Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia.

Origa R, Tatti F, Zappu A, Leoni GB, Dessì C, Moi P, Morittu M, Orecchia V, Denotti AR, Pilia MP, Anni F, Perra M, Casini MR, Barella S.

Am J Hematol. 2017 Nov;92(11):E627-E628. doi: 10.1002/ajh.24869. Epub 2017 Sep 25. No abstract available.

9.

Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.

Cadoni C, Pisanu A, Simola N, Frau L, Porceddu PF, Corongiu S, Dessì C, Sil A, Plumitallo A, Wardas J, Di Chiara G.

Neuropharmacology. 2017 Sep 1;123:385-394. doi: 10.1016/j.neuropharm.2017.06.008. Epub 2017 Jun 8.

PMID:
28603026
10.

Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000-2015.

Origa R, Anni F, Mereu L, Follesa I, Campus S, Dessì C, Foschini ML, Leoni G, Moi P, Morittu M, Orecchia V, Perra M, Zappu A, Podda RA.

Ann Hematol. 2017 Jun;96(6):1041-1042. doi: 10.1007/s00277-017-2963-4. Epub 2017 Mar 9. No abstract available.

PMID:
28280993
11.

Current growth patterns in children and adolescents with thalassemia major.

Origa R, Danjou F, Orecchia V, Zappu A, Dessì C, Foschini ML, Leoni GB, Moi P, Morittu M, Demurtas A, Loche S.

Blood. 2016 Nov 24;128(21):2580-2582. Epub 2016 Oct 13. No abstract available.

PMID:
27737888
12.

Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors.

Caocci G, Vacca A, Piras E, Serreli V, Dessi C, Marcias M, Risso P, La Nasa G.

Bone Marrow Transplant. 2016 Dec;51(12):1640-1641. doi: 10.1038/bmt.2016.243. Epub 2016 Sep 19. No abstract available.

PMID:
27643871
13.

Violence and mental disorders. A retrospective study of people in charge of a community mental health center.

Pinna F, Tusconi M, Dessì C, Pittaluga G, Fiorillo A, Carpiniello B.

Int J Law Psychiatry. 2016 Jul-Aug;47:122-8. doi: 10.1016/j.ijlp.2016.02.015. Epub 2016 May 11.

PMID:
27180213
14.

Assessment of UVA-Riboflavin Corneal Cross-Linking Using Small Amplitude Oscillatory Shear Measurements.

Aslanides IM, Dessi C, Georgoudis P, Charalambidis G, Vlassopoulos D, Coutsolelos AG, Kymionis G, Mukherjee A, Kitsopoulos TN.

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2240-5. doi: 10.1167/iovs.15-17956.

PMID:
27124315
15.

Network dynamics in nanofilled polymers.

Baeza GP, Dessi C, Costanzo S, Zhao D, Gong S, Alegria A, Colby RH, Rubinstein M, Vlassopoulos D, Kumar SK.

Nat Commun. 2016 Apr 25;7:11368. doi: 10.1038/ncomms11368.

16.

Cardiac and thrombotic complications in the peripartum period of a patient affected by beta-thalassemia intermedia: An unusual case.

Binaghi G, Congia D, Dessì C, Matta G, Pasqualucci D, Serra E, Porcu M.

Int J Cardiol. 2016 Jul 15;215:32-3. doi: 10.1016/j.ijcard.2016.04.066. Epub 2016 Apr 13. No abstract available.

PMID:
27107541
17.

Deferasirox and children: From clinical trials to the real world.

Origa R, Zappu A, Foschini ML, Leoni G, Morittu M, Moi P, Corpino M, Dessì C.

Am J Hematol. 2016 Jun;91(6):E304-5. doi: 10.1002/ajh.24353. Epub 2016 Apr 13. No abstract available.

18.

Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P.

Neuropsychopharmacology. 2016 Apr;41(5):1416-26. doi: 10.1038/npp.2015.295. Epub 2015 Sep 21.

19.

Thalassemia Major: Who Is Afraid of Serum Ferritin below 500 μg/l?

Pinna F, Carta R, Morittu M, Dessì C, Moi P, Leoni G, Foschini ML, Defraia E, Zappu A, Origa R.

Acta Haematol. 2015;134(3):183-4. doi: 10.1159/000371866. Epub 2015 May 27. No abstract available.

PMID:
26022742
20.

Thalassemia major between liver and heart: Where we are now.

Dessì C, Leoni G, Moi P, Danjou F, Follesa I, Foschini ML, Morittu M, Zappu A, Defraia E, Bina P, Cunico A, Civolani A, Podda RA, Origa R.

Blood Cells Mol Dis. 2015 Jun;55(1):82-8. doi: 10.1016/j.bcmd.2015.03.010. Epub 2015 Apr 6.

PMID:
25976473
21.

A decisional algorithm to start iron chelation in patients with beta thalassemia.

Danjou F, Cabantchik ZI, Origa R, Moi P, Marcias M, Barella S, Defraia E, Dessì C, Foschini ML, Giagu N, Leoni GB, Morittu M, Galanello R.

Haematologica. 2014 Mar;99(3):e38-40. doi: 10.3324/haematol.2013.098202. No abstract available.

22.

Synthesis and biological evaluation of novel delta (δ) opioid receptor ligands with diazatricyclodecane skeletons.

Loriga G, Lazzari P, Ruiu S, Marchese G, Manca I, Casu GL, Dessì C, Pinna GA, Asproni B, Murineddu G.

Eur J Med Chem. 2013 Nov;69:413-26. doi: 10.1016/j.ejmech.2013.09.014. Epub 2013 Sep 19.

PMID:
24090913
23.

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major.

Origa R, Danjou F, Cossa S, Matta G, Bina P, Dessì C, Defraia E, Foschini ML, Leoni G, Morittu M, Galanello R.

Br J Haematol. 2013 Nov;163(3):400-3. doi: 10.1111/bjh.12517. Epub 2013 Aug 16.

PMID:
24033185
24.

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.

La Nasa G, Caocci G, Efficace F, Dessì C, Vacca A, Piras E, Sanna M, Marcias M, Littera R, Carcassi C, Lucarelli G.

Blood. 2013 Sep 26;122(13):2262-70. doi: 10.1182/blood-2013-05-502658. Epub 2013 Aug 19.

PMID:
23958950
25.

Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.

Scherma M, Fattore L, Satta V, Businco F, Pigliacampo B, Goldberg SR, Dessi C, Fratta W, Fadda P.

Br J Pharmacol. 2013 Jun;169(4):820-33. doi: 10.1111/bph.12014.

26.

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine.

Grady RW, Galanello R, Randolph RE, Kleinert DA, Dessi C, Giardina PJ.

Haematologica. 2013 Jan;98(1):129-35. doi: 10.3324/haematol.2012.070607. Epub 2012 Aug 8.

27.

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major.

Alpendurada F, Smith GC, Carpenter JP, Nair SV, Tanner MA, Banya W, Dessi C, Galanello R, Walker JM, Pennell DJ.

J Cardiovasc Magn Reson. 2012 Jan 25;14:8. doi: 10.1186/1532-429X-14-8.

28.

Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.

Danjou F, Anni F, Perseu L, Satta S, Dessì C, Lai ME, Fortina P, Devoto M, Galanello R.

Haematologica. 2012 Jul;97(7):989-93. doi: 10.3324/haematol.2011.053504. Epub 2012 Jan 22.

29.

Association of endodontic infection with detection of an initial lesion to the cardiovascular system.

Cotti E, Dessì C, Piras A, Flore G, Deidda M, Madeddu C, Zedda A, Longu G, Mercuro G.

J Endod. 2011 Dec;37(12):1624-9. doi: 10.1016/j.joen.2011.09.006.

PMID:
22099894
30.

Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study.

Derchi G, Formisano F, Balocco M, Galanello R, Bina P, Dessì C, Piga A, Donato G, Cappellini MD, Cassinerio E, Quarta G, Melpignano A, Forni GL.

Eur J Echocardiogr. 2011 Mar;12(3):242-6. doi: 10.1093/ejechocard/jeq190. Epub 2011 Jan 28.

PMID:
21278193
31.

Can a chronic dental infection be considered a cause of cardiovascular disease? A review of the literature.

Cotti E, Dessì C, Piras A, Mercuro G.

Int J Cardiol. 2011 Apr 1;148(1):4-10. doi: 10.1016/j.ijcard.2010.08.011. Epub 2010 Sep 18. Review.

PMID:
20851474
32.

GABAB receptor activation exacerbates spontaneous spike-and-wave discharges in DBA/2J mice.

Bortolato M, Frau R, Orrù M, Fà M, Dessì C, Puligheddu M, Barberini L, Pillolla G, Polizzi L, Santoni F, Mereu G, Marrosu F.

Seizure. 2010 May;19(4):226-31. doi: 10.1016/j.seizure.2010.02.007. Epub 2010 Mar 15.

33.

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir.

Tommasi C, Ceccherini-Silberstein F, D'Arrigo R, Bellagamba R, Tempestilli M, Dessì C, Santoro MM, Forbici F, Nicastri E, Pucillo LP, Perno CF, Narciso P.

Scand J Infect Dis. 2010 Mar;42(3):237-9. doi: 10.3109/00365540903447018.

PMID:
20085429
34.

Endodontic treatment and hypotheses on an unusual case of dens invaginatus.

Demartis P, Dessì C, Cotti M, Cotti E.

J Endod. 2009 Mar;35(3):417-21. doi: 10.1016/j.joen.2008.12.002.

PMID:
19249608
35.

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM, Pennell DJ.

J Cardiovasc Magn Reson. 2008 Feb 25;10:12. doi: 10.1186/1532-429X-10-12.

36.

3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitors.

Loriga G, Ruiu S, Manca I, Murineddu G, Dessi C, Pani L, Pinna GA.

Bioorg Med Chem. 2007 Jun 1;15(11):3748-55. Epub 2007 Mar 16.

PMID:
17399987
37.

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.

Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ.

Circulation. 2007 Apr 10;115(14):1876-84. Epub 2007 Mar 19.

PMID:
17372174
38.

Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.

Murineddu G, Lazzari P, Ruiu S, Sanna A, Loriga G, Manca I, Falzoi M, Dessì C, Curzu MM, Chelucci G, Pani L, Pinna GA.

J Med Chem. 2006 Dec 14;49(25):7502-12.

PMID:
17149879
39.

Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.

Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, Anderson LJ, Walker JM, Pennell DJ.

J Cardiovasc Magn Reson. 2006;8(3):543-7.

PMID:
16755844
40.

Modulation of ATP-mediated contractions of the rat vas deferens through presynaptic cannabinoid receptors.

Tambaro S, Mongeau R, Dessi C, Pani L, Ruiu S.

Eur J Pharmacol. 2005 Nov 21;525(1-3):150-3. Epub 2005 Nov 3.

PMID:
16271359
41.

Combined therapy with deferiprone and desferrioxamine in thalassemia major.

Origa R, Bina P, Agus A, Crobu G, Defraia E, Dessì C, Leoni G, Muroni PP, Galanello R.

Haematologica. 2005 Oct;90(10):1309-14.

42.

Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays.

Tambaro S, Ruiu S, Dessi C, Mongeau R, Marchese G, Pani L.

J Pharmacol Exp Ther. 2005 Feb;312(2):710-7. Epub 2004 Oct 6.

PMID:
15470085
43.

[Relation between hypogonadism and malocclusion in beta-thalassemia major patients: analysis of 122 subjects].

Piras V, Tuveri F, Dessì C, Pittau R, Origa R, Basile R, Muroni PP, Pittau A.

Minerva Stomatol. 2003 May;52(5):241-6. Italian.

PMID:
12874543
44.

Co-inherited Gilbert's syndrome: a factor determining hyperbilirubinemia in homozygous beta-thalassemia.

Galanello R, Cipollina MD, Dessì C, Giagu N, Lai E, Cao A.

Haematologica. 1999 Feb;84(2):103-5.

45.

Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients.

Salhi Y, Costagliola D, Rebulla P, Dessi C, Karagiorga M, Lena-Russo D, de Montalembert M, Girot R.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):473-8.

PMID:
9715844
46.

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders.

Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, Lampis R, Cao A, Lai ME, De Virgiliis S.

Hepatology. 1996 Dec;24(6):1338-41.

PMID:
8938157
47.

Cryoglobulinemia in transfusion-dependent thalassemia major.

Dessì C, Clemente MG, Diana G, Congia M, Frau F, Lai ME, Mazzoleni AP, Balestrieri A, Cengiarotti L, Piano P, et al.

Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S149-51.

PMID:
8730496
48.

Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.

Cazzola M, De Stefano P, Ponchio L, Locatelli F, Beguin Y, Dessi C, Barella S, Cao A, Galanello R.

Br J Haematol. 1995 Mar;89(3):473-8.

PMID:
7734344
49.

Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients.

Costagliola DG, de Montalembert M, Lefrère JJ, Briand C, Rebulla P, Baruchel S, Dessi C, Fondu P, Karagiorga M, Perrimond H, et al.

Br J Haematol. 1994 Aug;87(4):849-52.

PMID:
7986727
50.

Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C.

Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessì C, et al.

J Pediatr. 1994 Jul;125(1):123-8.

PMID:
8021761

Supplemental Content

Support Center